液质联用法测定鹭鸶咯丸中马兜铃酸类成分
投稿时间:2022-12-28     点此下载全文
引用本文:谭乐俊,于新兰,林林,于凤蕊,牛艳,林永强,戴忠.液质联用法测定鹭鸶咯丸中马兜铃酸类成分[J].中国现代中药,2023,25(9):1985-1991
DOI:10.13313/j.issn.1673-4890.20221228002
摘要点击次数: 71
全文下载次数: 0
                    
作者中文名作者英文名单位中文名单位英文名E-Mail
谭乐俊 TAN Le-jun 山东省食品药品检验研究院 国家药品监督管理局胶类产品质量评价重点实验室/山东省中药标准创新与质量评价工程实验室/中药配方颗粒共性技术山东省工程研究中心,山东 济南 250101 Shandong Provincial Institute for Food and Drug Control, NMPA Key Laboratory for Quality Evaluation of Gelatin Products, Shandong Engineering Laboratory for Standard Innovation and Quality Evaluation of TCM, Shandong Engineering Research Center of Generic Technologies for Traditional Chinese Medicine Formula Granules, Jinan 250101, China  
于新兰 YU Xin-lan 新疆维吾尔自治区药品检验研究院,新疆 乌鲁木齐 830002 Xinjiang Uygur Autonomous Region Institute of Drug Control, Urumqi 830002, China  
林林 LIN Lin 山东省食品药品检验研究院 国家药品监督管理局胶类产品质量评价重点实验室/山东省中药标准创新与质量评价工程实验室/中药配方颗粒共性技术山东省工程研究中心,山东 济南 250101 Shandong Provincial Institute for Food and Drug Control, NMPA Key Laboratory for Quality Evaluation of Gelatin Products, Shandong Engineering Laboratory for Standard Innovation and Quality Evaluation of TCM, Shandong Engineering Research Center of Generic Technologies for Traditional Chinese Medicine Formula Granules, Jinan 250101, China  
于凤蕊 YU Feng-rui 山东省食品药品检验研究院 国家药品监督管理局胶类产品质量评价重点实验室/山东省中药标准创新与质量评价工程实验室/中药配方颗粒共性技术山东省工程研究中心,山东 济南 250101 Shandong Provincial Institute for Food and Drug Control, NMPA Key Laboratory for Quality Evaluation of Gelatin Products, Shandong Engineering Laboratory for Standard Innovation and Quality Evaluation of TCM, Shandong Engineering Research Center of Generic Technologies for Traditional Chinese Medicine Formula Granules, Jinan 250101, China  
牛艳 NIU Yan 山东省食品药品检验研究院 国家药品监督管理局胶类产品质量评价重点实验室/山东省中药标准创新与质量评价工程实验室/中药配方颗粒共性技术山东省工程研究中心,山东 济南 250101 Shandong Provincial Institute for Food and Drug Control, NMPA Key Laboratory for Quality Evaluation of Gelatin Products, Shandong Engineering Laboratory for Standard Innovation and Quality Evaluation of TCM, Shandong Engineering Research Center of Generic Technologies for Traditional Chinese Medicine Formula Granules, Jinan 250101, China  
林永强* LIN Yong-qiang 山东省食品药品检验研究院 国家药品监督管理局胶类产品质量评价重点实验室/山东省中药标准创新与质量评价工程实验室/中药配方颗粒共性技术山东省工程研究中心,山东 济南 250101 Shandong Provincial Institute for Food and Drug Control, NMPA Key Laboratory for Quality Evaluation of Gelatin Products, Shandong Engineering Laboratory for Standard Innovation and Quality Evaluation of TCM, Shandong Engineering Research Center of Generic Technologies for Traditional Chinese Medicine Formula Granules, Jinan 250101, China  
戴忠 DAI Zhong 中国食品药品检定研究院,北京 100050 National Institutes for Food and Drug Control, Beijing 100050, China  
基金项目:山东省重点研发计划重大科技创新工程项目(2021CXGC010511);山东省重点研发计划项目(2020RKB24001);山东省人文社会科学课题(2021-YYGL-44)
中文摘要:目的 为明确鹭鸶咯丸是否含有马兜铃酸Ⅰ等马兜铃酸类成分,建立其马兜铃酸类成分的液质联用检测分析方法。方法 采用岛津Shim-pack Velox C18色谱柱(100 mm×2.1 mm,2.7 μm),以甲醇-0.1%甲酸溶液(含5 mmol·L–1甲酸铵)为流动相梯度洗脱;电喷雾正离子模式(ESI+),多反应监测(MRM)模式,对鹭鸶咯丸中7个马兜铃酸类成分进行初步筛查,并建立3个马兜铃酸成分的液质联用检测方法。结果 15批鹭鸶咯丸样品中检出马兜铃酸Ⅰ(0.003~0.011 μg·g–1)、马兜铃酸Ⅳa(0.169~0.260 μg·g–1)和马兜铃内酰胺Ⅰ(0.036~0.169 μg·g–1),进样量在相应范围内线性关系良好(r≥0.999 9),平均加样回收率分别为96.1%(RSD为1.63%)、99.4%(RSD为1.27%)、96.4%(RSD为2.98%),精密度及方法重复性均良好。结论 所建立的方法准确、灵敏、可靠,可用于鹭鸶咯丸中7个马兜铃酸类成分的筛查,且可用于上述3个马兜铃酸成分的分析,可为鹭鸶咯丸的质量控制及其安全使用提供参考。
中文关键词:鹭鸶咯丸  液质联用  马兜铃酸Ⅰ  马兜铃酸Ⅳa  马兜铃内酰胺Ⅰ  安全性
 
Determination of Aristolochic Acids in Lusika Pills by Liquid Chromatography-mass Spectrometry
Abstract:Objective To establish a method for the determination of aristolochic acids including aristolochic acid Ⅰ in Lusika Pills with liquid chromatography-mass spectrometry (LC-MS).Methods Shimadzu Shim-pack Velox C18 column (100 mm×2.1 mm, 2.7 μm) was used for the gradient elution with methanol-0.1% formic acid solution (containing 5 mmol·L–1 ammonium formate) as the mobile phase. The electrospray ionization in positive ion mode (ESI+) and multiple-reaction monitoring (MRM) mode were used for initially screening of 7 aristolochic acids. Furthremore, the LC-MS method was established to detect 3 aristolochic acids.Results Aristolochic acid Ⅰ(0.003-0.011 μg·g–1), aristolochic acid Ⅳa (0.169-0.260 μg·g–1), and aristololactam Ⅰ (0.036-0.169 μg·g–1) were detected in all the 15 batches of samples. The established method showed good linearity within the corresponding range (r≥0.999 9). The average recovery of the three components was 96.1% (RSD of 1.63%), 99.4% (RSD of 1.27%), and 96.4% (RSD of 2.98%), respectively. The established method showed good precision and repeatability.Conclusion The established method is accurate, sensitive, and reliable and can be applied to the screening of aristolochic acids and determination of the above three components in Lusika Pills. The findings can provide a scientific basis for the quality control and safe application of Lusika Pills.
keywords:Lusika Pills  liquid chromatography-mass spectrometry  aristolochic acid Ⅰ  aristolochic acid Ⅳa  aristololactam Ⅰ  safety
查看全文   查看/发表评论  下载PDF阅读器